The global proglumide market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Proglumide is a drug that inhibits gastrointestinal motility (GC) and reduces gastric secretions. The drug acts as a cholecystokinin antagonist, which blocks both the CCKA and CCKB subtypes. The rise in the burden of peptic ulcers is one […]
